Overview Safety, PK and PD Study in Healthy Male Japanese Subjects Status: Completed Trial end date: 2006-08-01 Target enrollment: Participant gender: Summary Study assessing pharmacokinetics, pharmacodynamics, safety, and tolerability of oral doses of SCA-136 in healthy male Japanese subjects Phase: Phase 1 Details Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer